Experiment 453150

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationROWINSKY,EK: NOE,DA: ETTINGER,DS: CHRISTIAN,MC: LUBEJKO,BG: FISHMAN,EK: SARTORIUS,SE: BOYD,MR: DONEHOWER,RC:. (1993). PHASE I AND PHARMACOLOGICAL STUDY OF THE PULMONARY CYTOTOXIN 4-IPOMEANOL ON A SINGLE DOSE SCHEDULE IN LUNG CANCER PATIENTS: HEPATOTOXICITY IS DOSE LIMITING IN HUMANS.. 53(8)
Amount utilized
Compound isolated
Disease55 PATIENTS WITH ADVANCED NON-SMALL AND SMALL CELL LUNG CANCERS WERE USED IN THIS PHASE I STUDY. PATIENTS WERE GIVEN DOSES RANGING FROM 6.5 TO 16.2 MG/SQ.M. THE DOSE LIMITING TOXICITY WAS HEPATOCELLULAR TOXICITY. NEPHROTOXICITY AND REVERSIBLE PULMONARY TOXICITY WAS ALSO NOTED. NO OBJECTIVE ANTITUMOR RESPONSES WERE OBSERVED; HOWEVER, STABLE DISEASE PERSISTED FOR AT LEAST 8 COURSES IN 27% OF PATIENTS.
Dose amountVAR
Number1
Qualitative result.
AnimalHUMAN ADULT
Dose expressionDOSE